15 PorB, and OpaJ129 (class 5.5), by W.D. Zollinger

(Walter Reed Army Institute www.selleckchem.com/screening/anti-cancer-compound-library.html of Research, Washington, DC, USA). Antibodies to Omp85 and OpcA were produced at the Norwegian Institute of Public Health [16] and [17]. The meningococcal vaccine strain 44/76 (B:15:P1.7,16; ST-32) was cultivated in a 2.5 L fermentor in either the semi-synthetic FM containing yeast extract and casamino acids [6] or the synthetic MC.6M containing ferric citrate prepared as described [18]. FM consisted of solutions A and B which were mixed and sterile filtered. The concentrations per litre of the final medium of reagents from solution A were 0.02 g cysteine HCl, 30.0 g casamino acids, 3.50 g Na2HPO4·2H2O and 0.09 g KCl and from solution B 10.0 g glucose, 0.6 g MgSO4·7H2O and 10 mL dialysate from 10% (w/v) yeast extract in water. OMVs were prepared by extraction with Na-deoxycholate as described previously [6]. Three OMV batches were prepared from bacteria grown in each of the culture media. For analysis by 2D electrophoresis, the 6

samples were concentrated using Microcon YM-3 filter following the manufacturer’s instructions (Millipore, Livingston, UK), and reconstituted in lysis buffer containing 30 mM Tris, 7 M urea, 2 M thiourea and 2% Triton X-100, pH 8.5 [12]. The protein concentration of the samples was determined using the Bradford selleck chemical assay (Bio-Rad, Laboratories Inc., Hercules, USA). One OMV preparation from each growth medium, made by pooling similar amounts of protein from each of the three batches, was adsorbed to aluminium hydroxide adjuvant (Alhydrogel, Superfos Biosector, Copenhagen, Denmark) [6]. Groups of 12 female NMRI mice (Taconic M&B Ltd., Ry, Denmark) received MTMR9 two doses subcutaneously of 0.5 or 2.0 μg protein of each OMV vaccine three weeks apart. Control mice in groups of 6 received physiological saline. Blood samples were collected from the mice two weeks after the second dose. Samples of OMVs were boiled

for 5 min in sample buffer, containing SDS and mercaptoethanol [19], and separated in 12% polyacrylamide gels (7 cm × 6 cm). Gels were stained with Coomassie R-250 or silver [20]. Unstained gels, loaded with similar protein amounts of the OMV batches, were electrotransferred to nitrocellulose membranes [21] and the blots incubated with specific poly- or monoclonal antibodies. For analysis of the specific OMP antibody responses in mice, the gels were loaded with 50 μg OMVs and the blots subsequently cut into about 25 strips which were incubated overnight with the individual murine sera diluted 1:1000 with 3% bovine serum albumin in physiological saline in the presence or absence of 0.2% Empigen BB detergent (Albright & Wilson, Whitehaven, UK) [21]. Antibody binding was detected with 1:1000 dilution of rabbit anti-mouse Ig conjugated to horse radish peroxidase (DakoCytomation, Glostrup, Denmark). All strips were stained for 10 min with peroxidase substrate under identical conditions.